Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response
Zak Loring1,2, Daniel J Friedman1,2, Kasper Emerek1,3
1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Pacing and Clinical Electrophysiology : PACE
|April 15, 2020
Summary
A low electrocardiogram (ECG) lead one ratio (LOR) predicts worse outcomes after cardiac resynchronization therapy (CRT) in patients with left bundle branch block (LBBB). This ratio may identify high-risk individuals needing CRT.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- A low electrocardiogram (ECG) lead one ratio (LOR) is linked to reduced left ventricular ejection fraction (LVEF) and poorer outcomes in left bundle branch block (LBBB).
- The effect of LOR on cardiac resynchronization therapy (CRT) outcomes in LBBB patients remains unclear.
Purpose of the Study:
- To investigate the association between baseline ECG LOR and clinical outcomes following CRT implantation in LBBB patients.
- To evaluate the impact of LOR on echocardiographic changes, specifically LVEF and LV volumes, after CRT.
Main Methods:
- A cohort of 496 consecutive CRT-defibrillator recipients with LBBB was analyzed.
- Time to heart transplant, left ventricular assist device (LVAD) implantation, or death was compared between LOR groups (<12 vs. ≥12) using Cox-proportional hazard models.
- Changes in LVEF and LV volumes post-CRT were assessed based on LOR.
Main Results:
- A baseline LOR <12 was associated with a 1.69-fold increased risk of heart transplant, LVAD, or death (adjusted HR: 1.69; P=.01).
- Patients with LOR <12 showed less reduction in LV end-diastolic volume (-4% vs. -13%; P=.04) and LV end-systolic volume (-9% vs. -22%; P=.03) after CRT.
- In patients with QRS duration ≥150 ms, LOR <12 significantly increased the risk of adverse events (adjusted HR: 2.01; P=.008).
Conclusions:
- A low baseline ECG LOR (<12) is a predictor of worse outcomes after CRT in LBBB patients.
- The LOR may be particularly useful in identifying high-risk patients with a QRS duration ≥150 ms who may not benefit optimally from CRT.
- This ECG marker could aid in risk stratification for patients undergoing CRT implantation.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
380
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
380
Cardiomyopathy II: Dilated Cardiomyopathy
343
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
343
Cardiomyopathy III: Hypertrophic Cardiomyopathy
283
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
283
Heart Failure Drugs: Inotropic Agents
1.1K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K


